American Vanguard Corporation (AVD) posted a challenging QQ2 2024, with revenue of $128.2 million, a year-over-year decline of 3.45% and a quarter-over-quarter decline of 5.13%. Gross profit was $37.76 million, yielding a 29.45% gross margin, but the company reported negative EBITDA of $3.89 million and an operating loss of $9.23 million, culminating in a net loss of $11.72 million or $-0.42 per share. The results reflect a combination of softer demand for certain crop-protection products and continuation of expense pressures, alongside notable working capital intensity (inventory and receivables elevated relative to sales). Cash flow from operations was negative at $13.25 million, while financing activities produced a net inflow of $21.81 million, enabling a modest net increase in cash to $17.95 million at quarter end. The balance sheet remains liquid with current assets of $477.6 million and a current ratio of 2.22, but leverage remains meaningful: total debt stands at $234.6 million and net debt at $216.7 million, with an indebtedness profile (debt to assets ~29.1%, debt to equity ~66.4%). Management commentary indicates a continued emphasis on cost control and optimization of the core pesticide product portfolio, but there was no explicit full-year guidance issued in the QQ2 release. In the near term, performance hinges on margin restoration, working-capital management, and the ability to realize price/mix gains in higher-margin offerings, against a backdrop of industry cyclicality, weather-driven demand, and regulatory considerations in the agricultural inputs space.